Therapeutic Intranasal Delivery for Stroke and Neurological Disorders
The blood-brain-barrier prevented harmful materials entering the brain and in the meantime is a barricade to therapeutic drug delivery. Intranasal drug delivery to circumvent blood-brain-barrier was developed in the past, to take advantages of a secret passage from the olfactory epithelium into the...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | , , , |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Cham :
Springer International Publishing : Imprint: Springer,
2019.
|
Έκδοση: | 1st ed. 2019. |
Σειρά: | Springer Series in Translational Stroke Research,
|
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Preface
- Transnasal Induction of Therapeutic Hypothermia for Neuroprotection
- Hypoxia-Primed Stem Cell Transplantation in Stroke
- Therapeutic potential of intranasal drug delivery in preclinical studies of ischemic stroke and intracerebral hemorrhage
- Intranasal Drug Delivery after Intracerebral Hemorrhage
- Intranasal Treatment in Subarachnoid Hemorrhage
- Intranasal Delivery of Therapeutic Peptides for Treatment of Ischemic Brain Injury
- Intranasal delivering method in the treatment of ischemic stroke
- Intranasal Delivery of Drugs for Ischemic Stroke Treatment: Targeting IL-17A
- Intranasal tPA application for axonal remodeling in rodent stroke and traumatic brain injury models
- Therapeutic Intranasal Delivery for Alzheimer's disease
- Combination therapy of intranasal IGF-1 and hypothermia
- Intranasal Medication Delivery in Children for Brain Disorders
- Index.